American Journal of Medical Case Reports. 2014, 2(1), 22-22
DOI: 10.12691/AJMCR-2-1-7
Is VMAT Ultimate Treatment Modality for the Treatment of Prostate Cancer?
KP Prasad1,
1University of Texas, Texas, United States of America
Pub. Date: January 22, 2014
Cite this paper
KP Prasad. Is VMAT Ultimate Treatment Modality for the Treatment of Prostate Cancer?.
American Journal of Medical Case Reports. 2014; 2(1):22-22. doi: 10.12691/AJMCR-2-1-7
Abstract
Keywords
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
http://creativecommons.org/licenses/by/4.0/
References
[1] | H Takeshi. Dosimetric Comparison between the Intensity Modulated Radiation Therapy and Volumetric Modulated arc Therapy for Prostate Cancer- A Case Study. American Journal of Medical Case Reports 2014; 2(1): 1-3. |
|
[2] | Rana S. Intensity modulated radiation therapy versus volumetric intensity modulated arc therapy. Jrnl of Medical Radiation Scie 2013; 60: 81-83. |
|
[3] | Lu L. Dose calculation algorithms in external beam photon radiation therapy. Int J Cancer Ther Oncol 2013; 1:01025. |
|
[4] | Oyewale S. Dose prediction accuracy of collapsed cone convolution superposition algorithm in a multi-layer inhomogenous phantom. Int J Cancer Ther Oncol 2013; 1:01016. |
|
[5] | Rana S, Rogers K, Lee T, Reed D, Biggs C. Dosimetric impact of Acuros XB dose calculation algorithm in prostate cancer treatment using RapidArc. J Cancer Res Ther 2013; 9(3): 430-5. |
|
[6] | Mavroidis P. Clinical implementation of radiobiological measures in treatment planning. Why has it taken so long? Int J Cancer Ther Oncol 2013; 1(1):01019. |
|
[7] | Santana-Blank L, Rodríguez-Santana E, Reyes H, Santana-Rodríguez J, Santana-Rodríguez K. Laser photobiomodulation: A new promising player for the multi-hallmark treatment of advanced cancer. Int J Cancer Ther Oncol 2013; 1(1):01012. |
|
[8] | Santana-Blank L, Rodriguez-Santana E, Reyes H, Santana- Rodriguez J, Santana- Rodriguez K. Water-light interaction: A novel pathway for multi hallmark therapy in cancer. Int J Cancer Ther Oncol 2014; 2(1):02012. |
|